A multinational Phase 3 registrational trial of Vibegron.

Trial Profile

A multinational Phase 3 registrational trial of Vibegron.

Phase of Trial: Phase III

Latest Information Update: 20 Sep 2017

At a glance

  • Drugs Vibegron (Primary)
  • Indications Overactive bladder
  • Focus Registrational; Therapeutic Use
  • Sponsors Urovant Sciences
  • Most Recent Events

    • 20 Sep 2017 Planned initiation date changed to 1 Jan 2018.
    • 18 Sep 2017 According to an Urovant Sciences media release, the company plans to initiate this confirmatory phase III trial by early 2018.
    • 19 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top